Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
Mills-Peninsula
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial
Please contact: fastest@sutterhealth.org about study FASTEST
More information about the study can be found here: https://www.nihstrokenet.org/fastest/home
This research study may affect you or someone you know. Before the research study starts, we will consult with the community. We welcome your feedback and questions. Please click on the survey link below to let us know your thoughts. Thank you!
https://redcap.research.cchmc.org/surveys/?s=YALHC7W838